Executive Committee
The BCBC Executive Committee is composed of the BCBC Chair, BCBC Investigators - appointed every two years - and NIDDK program administrators.
| Member | Position |
|---|---|
Kristin Abraham, PhD
NIDDK/NIH |
animal models, developmental biology, signal transduction |
Olivier Blondel, Ph.D.
NIDDK/NIH |
Diabetes, beta-cell function and development, genomics, epigenomics, small molecules, humanized mouse models. |
Pedro Herrera, Ph.D.
University of Geneva Faculty of Medicine |
pancreas development; beta cell development and generation; regeneration; reprogramming; cell tracing; transgenic mice |
Mark Magnuson, M.D.
Vanderbilt University |
Pancreas Development, Mouse Models, Next Generation Sequencing, Cell Reprogramming |
Maike Sander, M.D.
University of California at San Diego |
Genetic control of pancreatic cell differentiation, using mouse and human embryonic stem cells as model systems. |
Sheryl Sato, Ph.D.
NIDDK/NIH |
Vertebrate Embryology, Stem Cells, Diabetes, Obesity |
Phil Smith
NIDDK |
Integrative Physiology, Obesity, and Genomics |
Chris Wright, D. Phil.
Vanderbilt University |
Molecular embryology, vertebrate embryogenesis, transcription factors, intercellular signaling, stem cells |
